Literature DB >> 17434771

The neurological evolution of Pearson syndrome: case report and literature review.

Hsiu-Fen Lee1, Huei-Jane Lee, Ching-Shiang Chi, Chi-Ren Tsai, Te-Kau Chang, Chau-Jong Wang.   

Abstract

BACKGROUND: Pearson syndrome (PS) is an uncommon specific syndrome among mitochondrial diseases. It has unique clinical presentations. AIMS: The purpose of this article is to clarify the neurological evolution, neuroimage findings, molecular genetic analysis and outcomes in PS cases with neurologic manifestations.
METHODS: We described the clinical progress of a female patient who was diagnosed as PS with a novel 6.0 kbp mitochondrial DNA deletion. She had typical clinical features of PS in early infancy followed by multiple organs involvement after the age of 1 year. At age 3, Kearns-Sayre syndrome (KSS) and Leigh syndrome (LS) developed. We also reviewed PS cases reported in the literature and analyzed the neurological evolution.
RESULTS: Total 55 PS cases, including our index case, had been reported. Among them, 11 cases had detailed clinical descriptions in terms of hypotonia, developmental delay, ataxia or tremor. In whom, PS might evolve into KSS and/or LS: three cases evolving into KSS; one case on the transition of KSS; three cases evolve into LS; our index case has both presentations. The neuroimage findings of PS were quite different which might be from normal to specific abnormal findings over the cerebral white matter, cerebellum, basal ganglion and brainstem. Among those cases, the molecular analysis revealed large-scale mitochondrial deletion around 3.1-6.0kbp. The outcome of PS was opposite: either early death before age 4 or survived beyond age 7.
CONCLUSIONS: The neurological features of PS have potential evolution changes that are from normal, mild neurological deficits to special mitochondrial syndromes: KSS and LS. Closely monitoring neurological symptoms, arranging eye fundus examinations and neuroimaging studies in cases with changes of neurological signs are crucial.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434771     DOI: 10.1016/j.ejpn.2006.12.008

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  17 in total

Review 1.  Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.

Authors:  Nadee Nissanka; Carlos T Moraes
Journal:  EMBO Rep       Date:  2020-02-19       Impact factor: 8.807

Review 2.  Mitochondrial deficiency in Cockayne syndrome.

Authors:  Morten Scheibye-Knudsen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2013-02-19       Impact factor: 5.432

3.  Pearson syndrome: a rare inborn error of metabolism with bone marrow morphology providing a clue to diagnosis.

Authors:  Jyothi Muni Reddy; Joe Jose; Anand Prakash; Shanthala Devi
Journal:  Sudan J Paediatr       Date:  2019

Review 4.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

5.  Pearson Syndrome: A Retrospective Cohort Study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica).

Authors:  Piero Farruggia; Andrea Di Cataldo; Rita M Pinto; Elena Palmisani; Alessandra Macaluso; Laura Lo Valvo; Maria E Cantarini; Assunta Tornesello; Paola Corti; Francesca Fioredda; Stefania Varotto; Baldo Martire; Isabella Moroni; Giuseppe Puccio; Giovanna Russo; Carlo Dufour; Marta Pillon
Journal:  JIMD Rep       Date:  2015-08-04

6.  Broadening the phenotypic spectrum of Pearson syndrome: Five new cases and a review of the literature.

Authors:  K Taylor Wild; Amy C Goldstein; Colleen Muraresku; Rebecca D Ganetzky
Journal:  Am J Med Genet A       Date:  2019-12-11       Impact factor: 2.802

7.  Early neurological impairment and severe anemia in a newborn with Pearson syndrome.

Authors:  Anne-Sophie Morel; Nadia Joris; Reto Meuli; Sébastien Jacquemont; Diana Ballhausen; Luisa Bonafé; Sarah Fattet; Jean-François Tolsa
Journal:  Eur J Pediatr       Date:  2008-06-14       Impact factor: 3.183

8.  Comprehensive clinical and genetic work-up of patients carrying single mtDNA deletions is warranted.

Authors:  Josef Finsterer
Journal:  Transl Pediatr       Date:  2021-06

9.  Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease.

Authors:  Alexander Broomfield; Mary G Sweeney; Cathy E Woodward; Carl Fratter; Andrew M Morris; James V Leonard; Lara Abulhoul; Stephanie Grunewald; Peter T Clayton; Michael G Hanna; Joanna Poulton; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2014-10-29       Impact factor: 4.982

10.  Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo.

Authors:  Oliver M Russell; Isabelle Fruh; Pavandeep K Rai; David Marcellin; Thierry Doll; Amy Reeve; Mitchel Germain; Julie Bastien; Karolina A Rygiel; Raffaele Cerino; Andreas W Sailer; Majlinda Lako; Robert W Taylor; Matthias Mueller; Robert N Lightowlers; Doug M Turnbull; Stephen B Helliwell
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.